Robert, 2021 - Google Patents
Plant lecithins as alpha-linolenic acid carriers: metabolic and inflammatory impacts associated with intestinal bioavailabilityRobert, 2021
View PDF- Document ID
- 13347992836330686262
- Author
- Robert C
- Publication year
External Links
Snippet
Recent research has demonstrated that certain synthetic emulsifiers may exert deleterious effects on gut and metabolic health. This, alongside the current rise in consumer awareness, has led to a general debate regarding the use of food additives. Nevertheless, certain …
- 235000010445 lecithin 0 title abstract 19
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wei et al. | Human milk fat substitutes: Past achievements and current trends | |
Ahmmed et al. | Marine omega‐3 (n‐3) phospholipids: A comprehensive review of their properties, sources, bioavailability, and relation to brain health | |
Abrahamse et al. | Development of the digestive system—experimental challenges and approaches of infant lipid digestion | |
Schuchardt et al. | Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil | |
Liu et al. | Dietary oils modify lipid molecules and nutritional value of fillet in Nile tilapia: A deep lipidomics analysis | |
Ye et al. | Lipid composition modulates the intestine digestion rate and serum lipid status of different edible oils: a combination of in vitro and in vivo studies | |
Park et al. | Influence of encapsulation of emulsified lipids with chitosan on their in vivo digestibility | |
Yao et al. | Design of nanoemulsion-based delivery systems to enhance intestinal lymphatic transport of lipophilic food bioactives: Influence of oil type | |
Moreira et al. | Evaluation of structured lipids with behenic acid in the prevention of obesity | |
US20040209953A1 (en) | Glyceride compositions and methods of making and using same | |
Cheong et al. | Lipid profiling, particle size determination, and in vitro simulated gastrointestinal lipolysis of mature human milk and infant formula | |
Porsgaard et al. | Lymphatic transport in rats of several dietary fats differing in fatty acid profile and triacylglycerol structure | |
Cheng et al. | Effect of different structural flaxseed lignans on the stability of flaxseed oil-in-water emulsion: An interfacial perspective | |
Baliyan et al. | Milk fat globule membrane concentrate as a nutritional supplement prevents age-related cognitive decline in old rats: A lipidomic study of synaptosomes | |
Robert et al. | Rapeseed lecithin increases lymphatic lipid output and α-linolenic acid bioavailability in rats | |
Jiang et al. | Comparative study on the digestion and absorption characteristics of n-3 LCPUFA-enriched phospholipids in the form of liposomes and emulsions | |
Murota et al. | Roe-derived phospholipid administration enhances lymphatic docosahexaenoic acid-containing phospholipid absorption in unanesthetized rats | |
Sehl et al. | In vitro lipolysis and lymphatic absorption of n-3 long-chain PUFA in the rat: influence of the molecular lipid species as carrier | |
Domoto et al. | The bioaccessibility of eicosapentaenoic acid was higher from phospholipid food products than from mono‐and triacylglycerol food products in a dynamic gastrointestinal model | |
Dell et al. | Lipid and fatty acid profiles in rats consuming different high‐fat ketogenic diets | |
US9186343B2 (en) | Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases | |
Hou et al. | Mechanism of fat globule size and surface composition regulating in vitro dynamic digestion, absorption and transport of structured emulsions | |
Wang et al. | Digestion, absorption, and metabolism characteristics of EPA-enriched phosphoethanolamine plasmalogens based on gastrointestinal functions in healthy mice | |
Infantes-Garcia et al. | Pre-duodenal lipid digestion of emulsions: Relevance, colloidal aspects and mechanistic insight | |
Robert | Plant lecithins as alpha-linolenic acid carriers: metabolic and inflammatory impacts associated with intestinal bioavailability |